New biocatalyst might boost the production of pharmaceutical ingredients

New biocatalyst might boost the production of pharmaceutical ingredients

New biocatalyst might boost the production of pharmaceutical ingredients

Fossil fuel usage, for any requirement, is now being frowned upon and rapidly replaced with eco-friendly and renewable sources of energy. This is the same for the bioeconomy, which is effectively changing its ways and processes towards being fuelled by biotechnology in place of fossils. Catalysts are agents that increase the rapidity of the chemical reaction and result in faster and magnified end-products. Presently, microorganisms and enzymes are at the peak of the interests and focus of researchers in their quest for finding new and more efficient catalysts, to quicken chemical reaction and their application in the pharmaceutics production. Now, a new enzyme has been discovered by a team of researchers and scientists from the University of Bayreuth, which is possibly the best biocatalyst discovered yet. The most important part is that it could help in the organic medicinal reactions to come up with medicines and cure that could help save lives.

The enzyme that the team has discovered is AmbDH3. They form ring-shaped blocks, which are known as tetrahydropyrans, which can accelerate natural processes and products. These products would then be used to treat diseases such as cancer and Alzheimer’s disease. Professor Dr. Frank Hahn commented on the enzyme’s future usage and application, saying, “I expect future applications for the enzyme AmbDH3 primarily in the production of active pharmaceutical ingredients, but also in the synthesis of fine chemicals. Our research group is confident that we will be able to discover further enzymes related to AmbDH3, which will further expand the repertoire of these biocatalysts. Our work has proven that biocatalysis can make a significant contribution to establishing a more natural resource-based economy. It thus contributes to solving central social challenges.”

The problem with using catalysts is that they are highly expensive and cannot be used to produce in bulk. The devising of biocatalysts like this could counter that problem and give a long-lasting solution to the production of effective pharmaceutical ingredients.